Legal Notes & Data Protection

About Us

invivoContrast GmbH was founded in 2008 by Prof. Dr. med. Matthias Bräutigam (former head of Imaging Diagnostic Research at Bayer Schering Pharma, Berlin) and Prof. Dr. med. Fabian Kießling (Chair of the Experimental Molecular Imaging, University Hospital, RWTH-Aachen) with the goal to support the imaging research community with easily accessible and reliable contrast agents for preclinical research.

In the beginning of 2009 invivoContrast GmbH concluded an exclusive licence agreement with Bayer Schering Pharma AG to provide invivoContrast GmbH with the preclinical MRI contrast agents Gadofluorine P and Gadomer 17 for research purposes.

invivoContrast GmbH is partner of Forsatum, a ”Hightech.NRW“ winning consortium aiming to standardize small animal imaging for basic and preclinical research and development.

In summer 2009 invivoContrast GmbH has concluded a collaboration agreement with Philips Technologie GmbH Research Laboratories, Aachen, in the field of preclinical imaging.

Summer 2010: We are happy to announce that Richard Hullihen from m2m Imaging Corp. will be our distributor for the U.S., Canada and Latin America. Richard is well known in the MRI business having spent 25 years with various manufacturers in technical and business management roles and currently as CEO of m2m Imaging, who provides probes, coils, and accessories to all the major MRI system manufacturers.